161 related articles for article (PubMed ID: 6861166)
1. Phase II study of hycanthone in patients with advanced colorectal carcinoma.
Schutt AJ; Dalton RJ; Kovach JS; Moertel CG; O'Connell MJ
Cancer Treat Rep; 1983 Jun; 67(6):593-4. PubMed ID: 6861166
[No Abstract] [Full Text] [Related]
2. Phase II trial of maytansine in patients with advanced colorectal carcinoma.
O'Connell MJ; Shani A; Rubin J; Moertel CG
Cancer Treat Rep; 1978 Aug; 62(8):1237-8. PubMed ID: 356981
[No Abstract] [Full Text] [Related]
3. Phase II evaluation of pyrazofurin in patients with advanced colorectal carcinoma.
Carroll DS; Kemeny NE; Gralla RJ
Cancer Treat Rep; 1979 Jan; 63(1):139-40. PubMed ID: 369686
[No Abstract] [Full Text] [Related]
4. Phase II evaluation of vindesine in patients with advanced colorectal carcinoma.
Carroll DS; Gralla RJ; Kemeny NE
Cancer Treat Rep; 1979; 63(11-12):2097-8. PubMed ID: 526944
[No Abstract] [Full Text] [Related]
5. Phase II trial of menogaril in patients with advanced colorectal carcinoma: an Illinois Cancer Council trial.
Locker GY; Kilton L; Hoeltgen T; Knop RH; Benson AB; Chernicoff D; Barrett J; Blough R; Johnson C
Cancer Treat Rep; 1987 Sep; 71(9):871-2. PubMed ID: 2957053
[No Abstract] [Full Text] [Related]
6. Phase II study of ftorafur in previously untreated and treated patients with advanced colorectal cancer.
Schutt AJ; Hahn RG; Moertel CG; O'Connell MJ; Rubin J; Creagan ET
Cancer Treat Rep; 1983 May; 67(5):505-6. PubMed ID: 6406062
[No Abstract] [Full Text] [Related]
7. Phase II study of N-methylformamide in patients with advanced colorectal cancer.
Tchekmedyian NS; Kaplan RS; Eisenberger M; Abrams J; Van Echo D
Cancer Treat Rep; 1987 May; 71(5):541-2. PubMed ID: 3567980
[No Abstract] [Full Text] [Related]
8. Phase II study of 3-deazauridine in advanced colorectal adenocarcinoma.
Bruno S; Creaven PJ; Ledesma E; Poster D; Yoon J; Mittelman A
Am J Clin Oncol; 1982 Feb; 5(1):69-71. PubMed ID: 7081140
[TBL] [Abstract][Full Text] [Related]
9. Phase II clinical trial of tricyclic nucleoside phosphate for advanced colorectal cancer.
O'Connell MJ; Rubin J; Hahn RG; Kvols LK; Moertel CG
Cancer Treat Rep; 1987 Mar; 71(3):333-4. PubMed ID: 3815402
[No Abstract] [Full Text] [Related]
10. [Treatment of schistosomiasis mansoni infection using hycanthone (our current experience in 3,400 cases)].
Huggins D
An Inst Hig Med Trop (Lisb); 1975; 3(1-4):261-5. PubMed ID: 1235036
[No Abstract] [Full Text] [Related]
11. Phase II trial of mitoxantrone in advanced colorectal cancer.
Bonnem EM; Mitchell EP; Woolley PV; Smith FP; Neefe J; Smith L; Schein PS
Cancer Treat Rep; 1982 Nov; 66(11):1995-6. PubMed ID: 7139642
[No Abstract] [Full Text] [Related]
12. Phase II trial of mitolactol in previously treated and untreated patients with advanced colorectal cancer: an Illinois Cancer Council trial.
Locker GY; Lanzotti V; Sweet D; Lad T; Khandekar J; Stiff P; Johnson C; Miller S
Cancer Treat Rep; 1984 Oct; 68(10):1303-4. PubMed ID: 6525605
[No Abstract] [Full Text] [Related]
13. Phase II trial of mitoxantrone in previously untreated patients with colorectal adenocarcinoma: A Southwest Oncology Group Study.
Cowan JD; Von Hoff DD; McDonald B; Talley RW; McCracken JD; Chen T
Cancer Treat Rep; 1982 Sep; 66(9):1779-80. PubMed ID: 7116355
[No Abstract] [Full Text] [Related]
14. [A clinical study (phase II) of a combination of 5-fluorouracil, vincristine and methyl CCNU in patients with advanced carcinoma of the large intestine].
Roth A; Kolarić K
Lijec Vjesn; 1983 Jun; 105(6):244-6. PubMed ID: 6633141
[No Abstract] [Full Text] [Related]
15. Phase II trial of 5-fluorouracil plus melphalan in colorectal carcinoma.
Presant CA; Ratkin G; Klahr C
Cancer Treat Rep; 1978 Mar; 62(3):461-2. PubMed ID: 348317
[No Abstract] [Full Text] [Related]
16. Phase II study of mitomycin C, cyclophosphamide, and methotrexate in drug-resistant colorectal carcinoma.
Presant CA; Ratkin G; Klahr C
Cancer Treat Rep; 1978 Apr; 62(4):549-50. PubMed ID: 350389
[No Abstract] [Full Text] [Related]
17. Phase II study of chlorozotocin in the treatment of advanced colorectal cancer.
Lawton JO; Giles GR; Hall J; MacAdam A; Hall R; Matheson T; Bird G
Cancer Treat Rep; 1981; 65(1-2):13-15. PubMed ID: 6452945
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic evolution of schistosomiasis mansoni. Results obtained with the use of hycanthone (Etrenol), during corticosteroid therapy].
Asfora J; Lúcia Coutinho Domingues A
An Inst Hig Med Trop (Lisb); 1974; 2(1-4):521-33. PubMed ID: 4462401
[No Abstract] [Full Text] [Related]
19. [Clinical trial with hycanthone in the treatment of schistosomiasis mansoni].
Huggins D
An Inst Hig Med Trop (Lisb); 1974; 2(1-4):553-9. PubMed ID: 4462403
[No Abstract] [Full Text] [Related]
20. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced colorectal carcinoma.
Carroll DS; Kemeny N; Lynch G; Wookcock T
Cancer Treat Rep; 1980; 64(10-11):1149-50. PubMed ID: 6893951
[No Abstract] [Full Text] [Related]
[Next] [New Search]
